文献速递呼吸危重症与机械通气呼吸道感染

系统性风湿病危重患者一年结局:多中心队列研究

One-Year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Cohort Study.
PubMed 文献 · Chest · 2020-04-11

该多中心队列研究纳入2006至2016年入住ICU的525例系统性风湿病(SRD)患者,评估院内及一年死亡率并识别死亡预测因素。结果显示院内死亡率为30.5%,一年死亡率为37.7%;年龄、既往糖皮质激素治疗、病情严重度与短期和长期死亡相关,Knaus量表C或D级及既往传统改善病情抗风湿药治疗独立关联一年死亡。

要点

  • SRD危重患者院内死亡率为30.5%,一年死亡率为37.7%。
  • 年龄、既往激素治疗和病情严重度与短期及长期死亡显著相关。
  • Knaus量表C或D级及既往传统DMARD治疗独立关联一年死亡。

核心结论

  • SRD危重患者ICU结局尚可,但一年死亡率仍较高。
  • 年龄、既往糖皮质激素治疗和危重程度与短期及长期死亡显著相关。
  • 一年死亡还独立关联既往健康状态和传统改善病情抗风湿药治疗。

研究设计与样本

  • 多中心队列研究,回顾性分析2006至2016年入住ICU的525例SRD患者记录。
  • 评估院内和一年死亡率,并识别死亡预测因素。

主要发现

  • 入ICU原因最常见为休克(40.8%)和急性呼吸衰竭(31.8%)。
  • 主要诊断为感染(39%)和SRD病情活动(35%)。
  • 院内死亡率为30.5%,一年死亡率为37.7%。
  • 与院内和一年死亡相关的预测因素分别为年龄、既往糖皮质激素治疗、简化急性生理评分II≥50、需要有创机械通气或需要肾脏替代治疗。
  • Knaus量表C或D级及既往传统改善病情抗风湿药治疗独立关联ICU入院后一年死亡。

临床怎么用

  • 对SRD危重患者应关注年龄、既往激素使用及病情严重度以评估死亡风险。
  • 需重视需要有创机械通气或肾脏替代治疗患者的短期和长期预后。
  • 既往健康状态差和传统DMARD治疗史提示一年死亡风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Critically ill patients with systemic rheumatic disease (SRD) have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality rates and, most importantly, long-term outcomes are scarce. RESEARCH QUESTION: The aim of this study was to assess short and long-term outcome of patients with SRD who were admitted to the ICU. STUDY DESIGN AND METHODS: All records of patients with SRD who were admitted to ICU between 2006 and 2016 were reviewed. In-hospital and one-year mortality rates were assessed, and predictive factors of death were identified. RESULTS: A total of 525 patients with SRD were included. Causes of admission were most frequently shock (40.8%) and acute respiratory failure (31.8%). Main diagnoses were infection (39%) and SRD flare-up (35%). In-hospital and one-year mortality rates were 30.5% and 37.7%, respectively. Predictive factors that were associated with in-hospital and one-year mortalities were, respectively, age, prior corticosteroid therapy, simplified acute physiology score II ≥50, need for invasive mechanical ventilation, or need for renal replacement therapy. Knaus scale C or D and prior conventional disease modifying antirheumatic drug therapy was associated independently with death one-year after ICU admission. INTERPRETATION: Critically ill patients with SRD had a fair outcome after an ICU stay. Increased age, prior corticosteroid therapy, and severity of critical illness were associated significantly with short- and long-term mortality rates. The one-year mortality rate was also associated with prior health status and conventional disease modifying antirheumatic drug therapy.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Larcher R, Pineton de Chambrun M, Garnier F, et al. One-Year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Cohort Study. Chest. 2020. PMID: 32289313. doi:10.1016/j.chest.2020.03.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。